Glucagon-like Peptide 1-Based Drugs and Pancreatic Safety

被引：1
|
作者：
Raschi, Emanuel [1 ]
Piccinni, Carlo [1 ]
Marchesini, Giulio [1 ]
机构：
[1] Univ Bologna, Dept Med & Surg Sci, Bologna, Italy
来源：
JAMA INTERNAL MEDICINE | 2013年 / 173卷 / 19期
关键词：
RISK;
D O I：
10.1001/jamainternmed.2013.8150
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1843 / 1843
页数：1
相关论文
共 50 条
  • [1] PANCREATIC SAFETY IN STUDIES OF THE GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST ALBIGLUTIDE
    Al-Kawas, Firas
    Anderson, Michelle Ann
    Enns, Robert
    Wilson, Timothy H.
    Johnson, Susan
    Mallory, Jason M.
    ENDOCRINE PRACTICE, 2019, 25 (07) : 698 - 716
  • [2] Pancreatitis, Pancreatic, and Thyroid Cancer With Glucagon-Like Peptide-1-Based Therapies
    Elashoff, Michael
    Matveyenko, Aleksey V.
    Gier, Belinda
    Elashoff, Robert
    Butler, Peter C.
    GASTROENTEROLOGY, 2011, 141 (01) : 150 - 156
  • [3] Changes in 24-Hour Urine Chemistry in Patients with Nephrolithiasis during Weight Loss with Glucagon-Like Peptide 1-Based Therapies
    Feghali, Karen
    Li, Xilong
    Maalouf, Naim M.
    KIDNEY360, 2024, 5 (11): : 1706 - 1712
  • [4] No pancreatic safety concern following glucagon-like peptide-1 receptor agonist therapies: A pooled analysis of cardiovascular outcome trials
    Liu, Ye
    Tian, Qing
    Yang, Jin
    Wang, Haining
    Hong, Tianpei
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2018, 34 (08)
  • [5] Safety issues with glucagon-like peptide-1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): Data from randomized controlled trials
    Monami, Matteo
    Nreu, Besmir
    Scatena, Alessia
    Cresci, Barbara
    Andreozzi, Francesco
    Sesti, Giorgio
    Mannucci, Edoardo
    DIABETES OBESITY & METABOLISM, 2017, 19 (09) : 1233 - 1241
  • [6] Comparative cardiovascular safety of glucagon-like peptide-1 receptor agonists versus other antidiabetic drugs in routine care: a cohort study
    Patorno, E.
    Everett, B. M.
    Goldfine, A. B.
    Glynn, R. J.
    Liu, J.
    Gopalakrishnan, C.
    Kim, S. C.
    DIABETES OBESITY & METABOLISM, 2016, 18 (08) : 755 - 765
  • [7] Glucagon-like peptide-1 receptor agonists in neoplastic diseases
    Ji, Lisan
    He, Xianzhen
    Min, Xinwen
    Yang, Handong
    Wu, Wenwen
    Xu, Hao
    Chen, Jun
    Mei, Aihua
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [8] Glucagon-Like Peptide 1 Receptor Agonists in Alzheimer's Disease
    Wang, Qiao-Qiao
    Yan, Xue
    Wang, Tian-Tian
    Zeng, Ling-Hui
    NEUROCHEMICAL JOURNAL, 2023, 17 (02) : 243 - 246
  • [9] The knowns and unknowns of glucagon-like peptide 1 agonists and perioperative care
    Mcisaac, Daniel I.
    Berrio-Valencia, Marta
    Miller, Elizabeth C.
    CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 2024, 71 (07): : 933 - 938
  • [10] Glucagon-like peptide-1 receptor agonists and pancreatic cancer: a meta-analysis with trial sequential analysis
    Pinto, Lana C.
    Falcetta, Mariana R.
    Rados, Dimitris, V
    Leitao, Cristiane B.
    Gross, Jorge L.
    SCIENTIFIC REPORTS, 2019, 9 (1)
12345